The latest Investing Matters Podcast episode with multi-award-winning fund manager and international bestselling author Lee Freeman-Shor has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 253.00
Bid: 251.00
Ask: 254.00
Change: 5.00 (2.02%)
Spread: 3.00 (1.195%)
Open: 248.00
High: 253.00
Low: 246.00
Prev. Close: 248.00
GFRD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Settlement of AWPR

23 Dec 2019 11:00

RNS Number : 8332X
Galliford Try PLC
23 December 2019
 

 

 

 

 

 

 

Galliford Try plc

Settlement agreed on Aberdeen Western Peripheral Route

 

Galliford Try plc ("Galliford Try"), the housebuilding, regeneration and construction group announces that, following a lengthy period of negotiation, the Aberdeen Western Peripheral Route ("AWPR") joint venture has substantially agreed settlement terms with the client in respect of the final account of this major infrastructure project. As a result of the settlement Galliford Try expects to receive a cash payment of around £32m and incur a write-off of £52m.

 

The settlement brings to a conclusion a complex and challenging project, averting a lengthy and costly litigation process. The settlement also removes a significant distraction and uncertainty, allowing the Construction business to focus on its core business, current and new projects which are expected to deliver improving margins, operating on multiple secured frameworks and in our chosen sectors. 

 

Taken together with an adverse adjudication award on an unrelated historical contract in the period, the Group will report an exceptional write-off of circa £61m at 31 December 2019.

 

The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary. This announcement contains inside information for the purposes of article 7 of EU Regulation 596/2014.

 

For further enquiries please contact:

 

Galliford Try

Graham Prothero, Chief Executive 01895 855001

Andrew Duxbury, Finance Director

 

Tulchan Communications

James Macey White 020 7353 4200

Martin Pengelley

Elizabeth Snow

 

 

Galliford Try plc is a leading UK housebuilding, regeneration and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2019, the Group generated revenue of £2.8bn. On 7 November 2019 the Group announced it had entered into an agreement with Bovis Homes Group PLC regarding a combination of Bovis Homes and the Group's housebuilding businesses, Linden Homes and Partnerships & Regeneration. The transaction is expected to complete on 3 January 2020.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBXLFLKLFEFBK
Date   Source Headline
7th Nov 20181:00 pmRNSTrading Statement
25th Oct 20183:12 pmRNSHolding(s) in Company
24th Oct 20183:00 pmRNSDirector/PDMR Shareholding
18th Oct 20181:00 pmRNSHolding(s) in Company
16th Oct 20181:00 pmRNSHolding(s) in Company
11th Oct 20187:00 amRNSCapital Markets Day
8th Oct 201812:30 pmRNSHolding(s) in Company
1st Oct 20184:00 pmRNSTotal Voting Rights
1st Oct 20182:00 pmRNSHolding(s) in Company
28th Sep 20183:00 pmRNSAnnual Financial Report
27th Sep 20184:00 pmRNSDirector/PDMR Shareholding
27th Sep 20184:00 pmRNSDirector/PDMR Shareholding
24th Sep 20186:00 pmRNSHolding(s) in Company
21st Sep 20184:00 pmRNSHolding(s) in Company
21st Sep 20183:18 pmRNSDirector/PDMR Shareholding
21st Sep 20183:11 pmRNSDirector/PDMR Shareholding
18th Sep 20183:30 pmRNSHolding(s) in Company
17th Sep 20183:00 pmRNSHolding(s) in Company
12th Sep 20187:00 amRNSFinal Results
4th Sep 201810:00 amRNSHolding(s) in Company
3rd Sep 20189:00 amRNSConfirmation of Directorate Change
21st Aug 201812:00 pmRNSHolding(s) in Company
1st Aug 20182:00 pmRNSTotal Voting Rights
24th Jul 20184:00 pmRNSHolding(s) in Company
19th Jul 201811:00 amRNSDirectorate Change
17th Jul 20187:00 amRNSTrading Statement
11th Jul 201812:00 pmRNSHolding(s) in Company
2nd Jul 201812:00 pmRNSTotal Voting Rights
27th Jun 20182:00 pmRNSBlock listing Interim Review
7th Jun 201810:00 amRNSDirector/PDMR Shareholding
5th Jun 20182:00 pmRNSDirector/PDMR Shareholding
1st Jun 201812:00 pmRNSTotal Voting Rights
25th May 201812:00 pmRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSTrading Statement
9th May 20184:00 pmRNSHolding(s) in Company
1st May 20184:00 pmRNSTotal Voting Rights
18th Apr 201812:00 pmRNSTotal Voting Rights
16th Apr 20183:15 pmRNSDirector/PDMR Shareholding
16th Apr 20182:43 pmRNSSuccessful Placing of Rights Issue Rump
16th Apr 20188:15 amRNSTotal Voting Rights
16th Apr 20187:25 amRNSResults of Rights Issue
9th Apr 20184:30 pmRNSDirector/PDMR Shareholding
6th Apr 20184:30 pmRNSHolding(s) in Company
6th Apr 201810:00 amRNSHolding(s) in Company
5th Apr 201810:30 amRNSDirector/PDMR Shareholding
3rd Apr 20184:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:00 pmRNSDirector/PDMR Shareholding
3rd Apr 201811:00 amRNSHolding(s) in Company
3rd Apr 201811:00 amRNSTotal Voting Rights
28th Mar 20182:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.